Skip to main content
MASS
NASDAQ Life Sciences

908 Devices Posts Record $19M Quarter, 35% Revenue Growth, Raises Guidance Floor

Tom Rudovsky · Reported by BusinessWire
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$11.95
Mkt Cap
$475.751M
52W Low
$5.025
52W High
$13.348
52W Position info
138% above low
Off High info
10% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

MASS has more than doubled off its 52-week low of $5.025.

Summary

908 Devices delivered Q3 2026 revenue of $19.0 million, up 35% year-over-year, with 308 devices placed in the quarter — a company record — and an installed base that grew 26% to 4,409 devices. The FTIR portfolio drove the product revenue jump to $15.8 million from $10.8 million a year ago, and the newly acquired NIRLab shipped roughly 100 units in its first full quarter. Recurring revenue of $5.1 million covered 27% of the top line, and adjusted gross margin held at 58%. The bottom line improved sharply: net loss from continuing operations narrowed to $4.6 million from $14.9 million, though most of that swing came from an $11.0 million noncash reduction in contingent consideration expense rather than operations — adjusted EBITDA loss was essentially flat at $1.7 million. Management raised the low end of full-year revenue guidance to $68.5 million-$70.0 million from $68.0 million-$70.0 million, implying 22%-25% growth, and the balance sheet carries $99.1 million in cash with no debt. This follows the Q2 print on August 11 that showed $16.1 million in revenue and a guidance raise; the acceleration to 35% growth is the key delta. The 8:30 am ET call today will be the venue for any detail on NIRLab pipeline and Q4 demand.

At the time of this announcement, MASS was trading at $11.95 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $475.8M. The 52-week trading range was $5.03 to $13.35. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

MASS - Latest Insights

MASS
Aug 11, 2026, 7:20 AM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $8.71
Real-time Price: $11.95 info
Change: +$3.24 (+37%) info
Market Cap: $475.751M info
MASS
Aug 11, 2026, 7:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.71
Real-time Price: $11.95 info
Change: +$3.24 (+37%) info
Market Cap: $475.751M info
MASS
Aug 11, 2026, 7:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $8.71
Real-time Price: $11.95 info
Change: +$3.24 (+37%) info
Market Cap: $475.751M info
MASS
Jul 08, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $7.88
Real-time Price: $11.95 info
Change: +$4.07 (+52%) info
Market Cap: $475.751M info
MASS
Jun 23, 2026, 12:46 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $8.90
Real-time Price: $11.95 info
Change: +$3.05 (+34%) info
Market Cap: $475.751M info